Company Analysis
Sign in

Vicore Pharma Holding AB (VCRE)

Nasdaq: VCRE · Pharmaceutical Preparations · filing with the SEC since 2026
Full chart Alerts Compare
Grade5.3
◀ Past 6.0● Present 5.1▶ Future 5.0
8 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart
The companyas filed
Revenuen/a
Net incomen/a
Earnings per sharen/a
Operating cash flown/a
Cashn/a
Debtn/a
Shareholders’ equityn/a
Shares, dilutedn/a
Return on equityn/a
The recordfrom its filings
Filings in 202613
Newest filingNov 5 · 6-K
Annual reportn/a
Quarterly reportn/a
Next report due10-K by Mar 31
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents grantedn/a
Filer categoryn/a
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
The record holds no annual figures yet.
As filed, in USD. Nothing here is a forecast.

News

Oct 13, 2026 · SEC EDGAR · Form SCHEDULE 13G
Large holder notice
Open the filing on sec.gov
Jun 30, 2026 · SEC EDGAR · Form SEC STAFF ACTION
Form SEC STAFF ACTION
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton VCRE · research, not advice